Precigen (PGEN) Depreciation & Amortization - Total (2014 - 2020)
Precigen (PGEN) reported Depreciation & Amortization - Total of -$577000.0 for Q4 2020, up 24.28% year-over-year from -$464280.9 in Q1 2020, and down 126.29% quarter-over-quarter from $2.2 million in Q3 2020.
Precigen (PGEN) Depreciation & Amortization - Total (2014 - 2020) Analysis & Trends
Precigen (PGEN) has 7 years of Depreciation & Amortization - Total data on file, last reported at -$577000.0 in Q4 2020.
- Depreciation & Amortization - Total for Q4 2020 came in at -$577000.0, up 24.28% year-over-year; the trailing twelve-month figure through Sep 2021 was -$577000.0 (down 107.94% YoY), and the FY2021 annual result was $6.2 million, down 16.74% from the prior year.
- Depreciation & Amortization - Total declined to -$577000.0 in Q4 2020 per PGEN's latest filing, from $2.2 million in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $3.6 million in Q2 2018 and troughed at -$1.8 million in Q4 2018.
- A 5-year average of $2.2 million and a median of $2.8 million in 2017 frame the typical range for Depreciation & Amortization - Total.
- The sharpest annual moves came in 2018 and 2019: Depreciation & Amortization - Total plunged 216.64% in 2018, then surged 56.85% in 2019.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $2.6 million in 2016, then plunged by 42.17% to $1.5 million in 2017, then sank by 216.64% to -$1.8 million in 2018, then surged by 56.85% to -$762000.0 in 2019, then increased by 24.28% to -$577000.0 in 2020.
- Business Quant data shows PGEN's Depreciation & Amortization - Total at -$577000.0 in Q4 2020, $2.2 million in Q3 2020, and $2.9 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -577,000.00 |
| Sep 30, 2020 | 2.20 Mn |
| Jun 30, 2020 | 2.90 Mn |
| Mar 31, 2020 | 2.93 Mn |
| Dec 31, 2019 | -762,000.00 |
| Sep 30, 2019 | 2.87 Mn |
| Jun 30, 2019 | 2.93 Mn |
| Mar 31, 2019 | 3.18 Mn |
| Dec 31, 2018 | -1.77 Mn |
| Sep 30, 2018 | 3.61 Mn |
| Jun 30, 2018 | 3.64 Mn |
| Mar 31, 2018 | 3.46 Mn |
| Dec 31, 2017 | 1.51 Mn |
| Sep 30, 2017 | 2.99 Mn |
| Jun 30, 2017 | 2.85 Mn |
| Mar 31, 2017 | 2.78 Mn |
| Dec 31, 2016 | 2.62 Mn |
| Sep 30, 2016 | 2.33 Mn |
| Jun 30, 2016 | 2.30 Mn |
| Mar 31, 2016 | 2.13 Mn |